"id","name","label","text","uuid:ID","instanceType","description"
"Objective_1","OBJ1","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg]).","33dd74fa-a795-42d5-8589-196f7a064705","OBJECTIVE","Main objective"
"Objective_2","OBJ2","","To document the safety profile of the xanomeline TTS.","c843563d-3d69-4db9-b608-2c0149d7fbb7","OBJECTIVE","Safety"
"Objective_3","OBJ3","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas.","c88c5914-edfc-4b09-9cdd-af4d95a1f36a","OBJECTIVE","Behaviour"
